166 related articles for article (PubMed ID: 7971289)
1. [18FDG-PET in intracranial meningiomas versus grading, proliferation index, cellular density and cytogenetic analysis].
Cremerius U; Striepecke E; Henn W; Weis J; Mull M; Lippitz B; Gilsbach J; Schröder JM; Zang KD; Böcking A
Nuklearmedizin; 1994 Aug; 33(4):144-9. PubMed ID: 7971289
[TBL] [Abstract][Full Text] [Related]
2. PET-study of intracranial meningiomas: correlation with histopathology, cellularity and proliferation rate.
Lippitz B; Cremerius U; Mayfrank L; Bertalanffy H; Raoofi R; Weis J; Böcking A; Büll U; Gilsbach JM
Acta Neurochir Suppl; 1996; 65():108-11. PubMed ID: 8738510
[TBL] [Abstract][Full Text] [Related]
3. Fasting improves discrimination of grade 1 and atypical or malignant meningioma in FDG-PET.
Cremerius U; Bares R; Weis J; Sabri O; Mull M; Schröder JM; Gilsbach JM; Buell U
J Nucl Med; 1997 Jan; 38(1):26-30. PubMed ID: 8998144
[TBL] [Abstract][Full Text] [Related]
4. Monosomy 1p is correlated with enhanced in vivo glucose metabolism in meningiomas.
Henn W; Cremerius U; Heide G; Lippitz B; Schröder JM; Gilsbach JM; Büll U; Zang KD
Cancer Genet Cytogenet; 1995 Feb; 79(2):144-8. PubMed ID: 7889508
[TBL] [Abstract][Full Text] [Related]
5. Glucose utilization by intracranial meningiomas as an index of tumor aggressivity and probability of recurrence: a PET study.
Di Chiro G; Hatazawa J; Katz DA; Rizzoli HV; De Michele DJ
Radiology; 1987 Aug; 164(2):521-6. PubMed ID: 3496626
[TBL] [Abstract][Full Text] [Related]
6. Kinetic analysis of glucose metabolism by FDG-PET versus proliferation index of Ki-67 in meningiomas--comparison with gliomas.
Tsuyuguchi N
Osaka City Med J; 1997 Dec; 43(2):209-23. PubMed ID: 9540343
[TBL] [Abstract][Full Text] [Related]
7. 13N-NH3 versus F-18 FDG in detection of intracranial meningioma: initial report.
Xiangsong Z; Xingchong S; Chang Y; Xiaoyan W; Zhifeng C
Clin Nucl Med; 2011 Nov; 36(11):1003-6. PubMed ID: 21975388
[TBL] [Abstract][Full Text] [Related]
8. Cytogenetic changes in 67 cranial and spinal meningiomas: relation to histopathological and clinical pattern.
Doco-Fenzy M; Cornillet P; Scherpereel B; Depernet B; Bisiau-Leconte S; Ferre D; Pluot M; Graftiaux JP; Teyssier JR
Anticancer Res; 1993; 13(4):845-50. PubMed ID: 8352553
[TBL] [Abstract][Full Text] [Related]
9. Intratumoral patterns of clonal evolution in meningiomas as defined by multicolor interphase fluorescence in situ hybridization (FISH): is there a relationship between histopathologically benign and atypical/anaplastic lesions?
Sayagués JM; Tabernero MD; Maíllo A; Espinosa A; Rasillo A; Díaz P; Ciudad J; López A; Merino M; Gonçalves JM; Santos-Briz A; Morales F; Orfao A
J Mol Diagn; 2004 Nov; 6(4):316-25. PubMed ID: 15507670
[TBL] [Abstract][Full Text] [Related]
10. Cytogenetic and proliferative potentials in meningiomas.
Debiec-Rychter M; Biernat W; Limon J; Kordek R; Izycka E; Borowska-Lehman J; Imieliński B; Liberski PP
Pol J Pathol; 1999; 50(4):243-8. PubMed ID: 10721264
[TBL] [Abstract][Full Text] [Related]
11. Clinical characteristics of meningiomas assessed by ¹¹C-methionine and ¹⁸F-fluorodeoxyglucose positron-emission tomography.
Arita H; Kinoshita M; Okita Y; Hirayama R; Watabe T; Ishohashi K; Kijima N; Kagawa N; Fujimoto Y; Kishima H; Shimosegawa E; Hatazawa J; Hashimoto N; Yoshimine T
J Neurooncol; 2012 Apr; 107(2):379-86. PubMed ID: 22089887
[TBL] [Abstract][Full Text] [Related]
12. Parapharyngeal meningioma extending from the intracranial space evaluated by FDG PET.
Kado H; Ogawa T; Okudera T; Kanno I; Hatazawa J; Uemura K
J Nucl Med; 1998 Feb; 39(2):302-4. PubMed ID: 9476940
[TBL] [Abstract][Full Text] [Related]
13. Correspondence of tumor localization with tumor recurrence and cytogenetic progression in meningiomas.
Ketter R; Rahnenführer J; Henn W; Kim YJ; Feiden W; Steudel WI; Zang KD; Urbschat S
Neurosurgery; 2008 Jan; 62(1):61-9; discussion 69-70. PubMed ID: 18300892
[TBL] [Abstract][Full Text] [Related]
14. Atypipcal intracranial meningiomas.
Podlas H; Snyckers FD
S Afr Med J; 1980 Jan; 57(3):85-90. PubMed ID: 7404110
[TBL] [Abstract][Full Text] [Related]
15. Genomic landscape of intracranial meningiomas.
Bi WL; Abedalthagafi M; Horowitz P; Agarwalla PK; Mei Y; Aizer AA; Brewster R; Dunn GP; Al-Mefty O; Alexander BM; Santagata S; Beroukhim R; Dunn IF
J Neurosurg; 2016 Sep; 125(3):525-35. PubMed ID: 26771848
[TBL] [Abstract][Full Text] [Related]
16. Correlation of apparent diffusion coefficient with Ki-67 proliferation index in grading meningioma.
Tang Y; Dundamadappa SK; Thangasamy S; Flood T; Moser R; Smith T; Cauley K; Takhtani D
AJR Am J Roentgenol; 2014 Jun; 202(6):1303-8. PubMed ID: 24848829
[TBL] [Abstract][Full Text] [Related]
17. Advanced Imaging of Intracranial Meningiomas.
Tamrazi B; Shiroishi MS; Liu CS
Neurosurg Clin N Am; 2016 Apr; 27(2):137-43. PubMed ID: 27012378
[TBL] [Abstract][Full Text] [Related]
18. Prediction of Meningioma WHO Grade Using PET Findings: A Systematic Review and Meta-Analysis.
Slot KM; Verbaan D; Buis DR; Schoonmade LJ; Berckel BNM; Vandertop WP
J Neuroimaging; 2021 Jan; 31(1):6-19. PubMed ID: 33135239
[TBL] [Abstract][Full Text] [Related]
19. C-11 methionine and F-18 FDG uptake in a patient with meningioma and glioblastoma multiforme.
Korkmaz M; Kim EE; Wong FC; Podoloff DA
Clin Nucl Med; 1996 Jul; 21(7):580-2. PubMed ID: 8818480
[No Abstract] [Full Text] [Related]
20. Glucose and methionine uptake and proliferative activity in meningiomas.
Iuchi T; Iwadate Y; Namba H; Osato K; Saeki N; Yamaura A; Uchida Y
Neurol Res; 1999 Oct; 21(7):640-4. PubMed ID: 10555183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
